Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

ClinicalTrials.gov ID: NCT00672139

Public ClinicalTrials.gov record NCT00672139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Extension Study To Assess The Safety Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Subjects With Advanced Illness And Opioid-Induced Constipation

Study identification

NCT ID
NCT00672139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
156 participants

Conditions and interventions

Interventions

  • Methylnaltrexone bromide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Dec 31, 2012
Completion
Apr 30, 2013
Last update posted
Mar 6, 2018

2008 – 2013

United States locations

U.S. sites
26
U.S. states
11
U.S. cities
23
Facility City State ZIP Site status
Salix Investigational Site Mobile Alabama 36604
Salix Investigational Site Laguna Hills California 92637
Salix Investigational Site Lancaster California 93534
Salix Investigational Site Aurora Colorado 80045
Salix Investigational Site Auburndale Florida 33823
Salix Investigational Site Hudson Florida 34667
Salix Investigational Site Lakeland Florida 33805
Salix Investigational Site Lakeland Florida 33815
Salix Investigational Site Miami Springs Florida 33166
Salix Investigational Site Ruskin Florida 33573
Salix Investigational Site Sebring Florida 33870
Salix Investigational Site Tampa Florida 33609
Salix Investigational Site Tampa Florida 33612-9416
Salix Investigational Site Tampa Florida 33619
Salix Investigational Site Temple Terrace Florida 33617
Salix Investigational Site Orange New Jersey 07018
Salix Investigational Site Flat Rock North Carolina 28731
Salix Investigational Site Winston-Salem North Carolina 27103-5766
Salix Investigational Site Cleveland Ohio 44119
Salix Investigational Site Philadelphia Pennsylvania 19111
Salix Investigational Site Austin Texas 78757
Salix Investigational Site Houston Texas 77030
Salix Investigational Site American Fork Utah 84003
Salix Investigational Site Orem Utah 84058
Salix Investigational Site Provo Utah 84604
Salix Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00672139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →